Liver tumors: Monitoring embolization in rabbits with VX2 tumors - Transcatheter intraarterial first-pass perfusion MR imaging

Radiology

Volumn 245, Issue 1, 2007, Pages 130-139

  Wang, Dingxin ^a,b   Bangash, Affaan K ^a   Rhee, Thomas K ^a   Woloschak, Gayle E ^a   Paunesku, Tatjana ^a   Salem, Riad ^a   Omary, Reed A ^a,b   Larson, Andrew C ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Northwestern University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL EMBOLISM; CONTROLLED STUDY; LIVER ANGIOGRAPHY; LIVER PERFUSION; LIVER TUMOR; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RABBIT; TUMOR BLOOD FLOW;

ANGIOGRAPHY, DIGITAL SUBTRACTION; ANIMALS; EMBOLIZATION, THERAPEUTIC; LIVER NEOPLASMS, EXPERIMENTAL; MAGNETIC RESONANCE IMAGING; RABBITS;

EID: 34548691483     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2451061689     Document Type: Article

References (27)

1. Furui S, Otomo K, Itai Y, Iio M. Hepatocellular carcinoma treated by transcatheter arterial embolization: progress evaluated by computed tomography. Radiology 1984;150(3):773-778.
2. Konno T. Targeting cancer chemotherapeutic agents by use of lipiodol contrast medium. Cancer 1990;66(9):1897-1903.
3. Guo WJ, Li J, Chen Z, et al. Transient increased expression of VEGF and MMP-1 in a rat liver tumor model after hepatic arterial occlusion. Hepatogastroenterology 2004;51(56):381-386.
4. Pandharipande PV, Krinsky GA, Rusinek H, et al. Perfusion imaging of the liver: current challenges and future goals. Radiology 2005;234(3):661-673.
5. Materne R, Smith AM, Peeters F, et al. Assessment of hepatic perfusion parameters with dynamic MRI. Magn Reson Med 2002;47(1):135-142.
6. Scharf J, Zapletal C, Hess T, et al. Assessment of hepatic perfusion in pigs by pharmacokinetic analysis of dynamic MR images. J Magn Reson Imaging 1999;9(4):568-572.
7. Kubota K, Hisa N, Nishikawa T, et al. Evaluation of hepatocellular carcinoma after treatment with transcatheter arterial chemoembolization: comparison of Lipiodol-CT, power Doppler sonography, and dynamic MRI. Abdom Imaging 2001;26(2):184-190.
8. Zhao JG, Feng GS, Kong XQ, Li X, Li MH, Cheng YS. Changes of tumor microcirculation after transcatheter arterial chemoembolization: first pass perfusion MR imaging and Chinese ink casting in a rabbit model. World J Gastroenterol 2004;10(10):1415-1420.
9. Kamel IR, Bluemke DA, Eng J, et al. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma. J Vasc Interv Radiol 2006;17(3):505-512.
10. Li W, Brophy DP, Chen Q, Edelman RR, Prasad PV. Semiquantitative assessment of uterine perfusion using first pass dynamic contrast-enhanced MR imaging for patients treated with uterine fibroid embolization. J Magn Reson Imaging 2000;12(6):1004-1008.
11. Wilson MW, Kerlan RK, Fidelman NA, et al. Hepatocellular carcinoma: regional therapy with a magnetic targeted carrier bound to doxorubicin in a dual MR imaging/ conventional angiography suite - initial experience with four patients. Radiology 2004;230(1):287-293.
12. Larson AC, Rhee TK, Deng J, et al. Comparison between intravenous and intraarterial contrast injection for dynamic 3D MRI of liver tumors in the VX2 rabbit model. J Magn Reson Imaging 2006;24(1):242-247.
13. Materne R, Van Beers BE, Smith AM, et al. Non-invasive quantification of liver perfusion with dynamic computed tomography and a dual-input one-compartmental model. Clin Sci 2000;99(6):517-525.
14. Ramirez LH, Julieron M, Bonnay M, et al. Stimulation of tumor growth in vitro and in vivo by suramin on the VX2 model. Invest New Drugs 1995;13(1):51-53.
15. Geschwind JF, Artemov D, Abraham S, et al. Chemoembolization of liver tumor in a rabbit model: assessment of tumor cell death with diffusion-weighted MR imaging and histologic analysis. J Vasc Interv Radiol 2000;11(10):1245-1255.
16. Laurent A, Wassef M, Chapot R, et al. Partition of calibrated tris-acryl gelatin microspheres in the arterial vasculature of embolized nasopharyngeal angiofibromas and paragangliomas. J Vasc Interv Radiol 2005;16(4):507-513.
17. Deng J, Rhee TK, Sato KT, et al. In vivo diffusion-weighted imaging of liver tumor necrosis in the VX2 rabbit model at 1.5 Tesla. Invest Radiol 2006;41(4):410-414.
18. Fenchel M, Helber U, Simonetti OP, et al. Multislice first-pass myocardial perfusion imaging: comparison of saturation recovery (SR)-TrueFISP-two-dimensional (2D) and SR-TurboFLASH-2D pulse sequences. J Magn Reson Imaging 2004;19(5):555-563.
19. Takayasu K, Maeda T, Iwata R. Sensitivity of superselective arteriography for small hepatocellular carcinoma compared with proximal arteriography and computed tomography during superselective arteriography. Jpn J Clin Oncol 2002;32(6):191-195.
20. Yoshimatsu S, Inoue Y, Ibukuro K, Suzuki S. Hypovascular hepatocellular carcinoma undetected at angiography and CT with iodized oil. Radiology 1989;171(2):343-347.
21. Liapi E, Hong K, Georgiades CS, Geschwind JF. Three-dimensional rotational angiography: introduction of an adjunctive tool for successful transarterial chemoembolization. J Vasc Interv Radiol 2005;16(9):1241-1245.
22. Collins DJ, Padhani AR. Dynamic magnetic resonance imaging of tumor perfusion. IEEE Eng Med Biol Mag 2004;23(5):65-83.
23. Evelhoch JL. Key factors in the acquisition of contrast kinetic data for oncology. J Magn Reson Imaging 1999;10(3):254-259.
24. Lankester KJ, Taylor NJ, Stirling JJ, et al. Effects of platinum/taxane based chemotherapy on acute perfusion in human pelvic tumours measured by dynamic MRI. Br J Cancer 2005;93(9):979-985.
25. Dumoulin CL, Souza SP, Darrow RD. Real-time position monitoring of invasive devices using magnetic resonance. Magn Reson Med 1993;29(3):411-415.
26. Wilson MW, Fidelman N, Weber OM, et al. Experimental renal artery embolization in a combined MR imaging/angiographic unit. J Vasc Interv Radiol 2003;14(9 pt 1):1169-1175.
27. Fidelman N, Wilson MW, Weber OM et al. Real-time MR properties of particulate embolic agents tested in a dynamic flow model. J Vasc Interv Radiol 2002;13(6):613-618.